Hypha Labs, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $655.6K
- Price
- $0.004
- % Change (Daily % change from the live per-ticker quote feed.)
- -13.04%
- Volume
- 11.0K
About
Hypha Labs, Inc. focuses on the investigation, development, and market release of bioreactor systems across the United States. Their key offering is the Hypha Micropearl bioreactor, a specialized household device engineered to rapidly cultivate beneficial mushrooms for dietary intake. Founded in 2010, the company is officially based in Las Vegas, Nevada.
Quick stats
Shares outstanding163.9M
Computed float150.6M
Float / shares91.9%
Cash runway (months)1.9
Key info
SectorHealthcare
IndustryMedical - Diagnostics & Research
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001502966
Websitehttps://hyphalabs.com
AI Summary
AI-generated1/5
minorbullishoperations update
Hypha Labs Targets Disruptive Mushroom Active Ingredient Production
Hypha Labs (OTCQB: FUNI) is promoting its Mushroom Accelerator biomanufacturing platform, which it says produces mushroom-derived biological material in about eight days versus an approximately 90-day conventional cultivation benchmark.
The company targets potential production cost savings of up to 80% via automation and its proprietary Micropearls starting material for nutraceutical, supplement, and functional-beverage ingredients.
A collaboration with Mycology Resources combines Hypha's production technology with mushroom genetics and extraction expertise to support commercial scale-up; no revenue, orders, or commercial commitments were disclosed.
Red flags
- Promotional-style release with forward-looking, unverified company estimates; no commercial orders or revenue disclosed
- OTCQB micro-cap; market-size figures are third-party TAM projections, not company fundamentals